Contact us | Sitemap | Imprint
Deutsch | English
CompanyTechnology Investor RelationsNews & Events

NascaCell Technologies AG i.L.

The general meeting held on the 30th of Jannuary 2009 decided the liquidation of the lompany. Liquidator ("Abwickler") will be Thomas Mayrhofer (attorney-at-law).

 

 

The new generation of biomolecules

Aptamers and Microbodies™ are a new generation
of biomolecules.

Aptamers offer improved, broadened and accelerated
modern drug discovery.

Microbodies™ are excellent candidates for the development
of drugs and technical products.

 

no news in this list.

.... more news

Services

Info-Service
Fact Sheet (pdf; 0,4 MB)
Aptamer Applications